Domestically Pioneering and Globally Leading.

Establishing a novel method for high-throughput disease diagnosis and follow-up based on body fluids, particularly trace peripheral serum. This innovation enables the R&D and commercialization of hardware/software products for a spectroscopy-based platform that carries detection kits, delivering more accurate, convenient, and cost-effective pan-disease screening services (covering three or more diseases). 

Strong original innovation capability; Broad market prospects